In the LabFDA orders Zafgen to halt clinical trial for obesity drug By Robert Weisman — Boston GlobeDec. 3, 2015 Reprints Zafgen FDA orders Zafgen to halt clinical trial for obesity drug About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags clinical trials FDA zafgen
Health Tech Associated Press Black men were likely underdiagnosed with lung problems because of bias in software, study suggests
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Fake medical devices, real cancer drugs, & curious Ozempic effects
Exclusive Brittany Trang STAT Plus: Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies
Exclusive Rachel Cohrs STAT Plus: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
Health Tech Casey Ross, Brittany Trang and Mario Aguilar STAT Plus: What does generative AI mean for health care? We asked the experts